G&E Herbal Biotechnology Co., Ltd.
4911
Rank in Stocks
#22466
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise,... G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
Share Price
$0.77278103
Last synced: 2026-11-10
Market Cap
$53.18M
Change (1 day)
0.20%
Change (1 year)
-46.77%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade G&E Herbal Biotechnology Co., Ltd. (4911)
Category
Healthcare
Operating Margin for G&E Herbal Biotechnology Co., Ltd. (4911)
Operating Margin as of November 2026 TTM: 38.46%
According to G&E Herbal Biotechnology Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 38.46%. At the end of 2025 the company had an operating margin of 49.27%.
Operating Margin history for G&E Herbal Biotechnology Co., Ltd. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 38.46% | -21.94% |
| 2025 | 49.27% | 2.56% |
| 2024 | 48.04% | 8.03% |
| 2023 | 44.47% | 297.41% |
| 2022 | 11.19% | -114.06% |
| 2021 | -79.61% | 45.25% |
| 2020 | -54.81% | -66.45% |
| 2019 | -163.36% | -91.07% |
| 2018 | -1,829.73% | 882.09% |
| 2017 | -186.31% | 115.06% |
| 2016 | -86.63% | 41.90% |
| 2015 | -61.05% | 1,306.68% |
| 2014 | -4.34% | -94.15% |
| 2013 | -74.25% | -16.97% |
| 2012 | -89.43% | 22.14% |
| 2011 | -73.22% | 36.76% |
| 2010 | -53.54% | 230.90% |
| 2009 | -16.18% | -54.15% |
| 2008 | -35.29% | -55.94% |
| 2007 | -80.10% | -16.33% |
| 2006 | -95.73% | 1,174.70% |
| 2005 | -7.51% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -99.00% |
US
|
|
| -149.01% | -103.87% |
US
|
|
| 25.57% | -99.34% |
AU
|
|
| 31.23% | -99.19% |
BE
|
|
| 29.35% | -99.24% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about G&E Herbal Biotechnology Co., Ltd.'s operating margin
What is G&E Herbal Biotechnology Co., Ltd.'s operating margin?
G&E Herbal Biotechnology Co., Ltd.'s operating margin is 38.46%, as of Nov 2026.
What was G&E Herbal Biotechnology Co., Ltd.'s operating margin in 2025?
In 2025, G&E Herbal Biotechnology Co., Ltd.'s operating margin was 49.27%, compared with 48.04% in 2024.
How has G&E Herbal Biotechnology Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, G&E Herbal Biotechnology Co., Ltd.'s operating margin was highest in 2025 (49.27%) and lowest in 2021 (-79.61%).
How does G&E Herbal Biotechnology Co., Ltd.'s operating margin compare with similar companies?
G&E Herbal Biotechnology Co., Ltd.'s operating margin (38.46%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.